In breast cancer, Deng et al. elucidated that RCAN1.4 was transcriptionally driven in a super-enhancer manner by the transcription of RUNX family transcription factor 3 (RUNX3), which acted as an oncogene to promote tumor growth [38]. Here, RUNX3 is linked to breast carcinoma.